Biotech
SAN DIEGO, CA: Regen Sees Feedback From Presentation and Potential Collaborations Stemming From Conference Invaluable in Further Expansion of the Company's Research ...
TUSTIN, CA: SUNRISE Phase III Lung Cancer Trial for Peregrine's Lead Immuno-Oncology Candidate Bavituximab Operational at Over 150 Sites Worldwide; Data From Immuno-Oncology Development Program Shows Potenti ...
NEWARK, DE: NEWARK, DE -- (Marketwired) -- 12/10/14 -- iBio, Inc. (NYSE MKT: IBIO), a leader in biotechnology for developing and manufacturing plant-made pharmaceutical products, will provide shareholders and at ...
MANCHESTER, NH: The Joslin Diabetes Center in Boston Will Be the Lead Clinic in the Multi-Center, Multi-Country Trial; The Company Expects to Enroll up to 360 Patients in the 24 Week Study, Which Is Expected to Begin ...
TUSTIN, CA: State-of-the-Art Facility Design Using Modular Clean Rooms and Fully-Disposable Technologies Provide Flexibility to Meet Growing Production Demands; Facility Expected to Be Ready for cGMP Production i ...
BEVERLY, MA: Phase 1 Study Demonstrates Prurisol Eligible for FDA 505(b)(2) Regulatory Path ...
HALIFAX, NOVA SCOTIA: DPX-Survivac vaccine is a potential maintenance therapy for newly diagnosed ovarian cancer patients following initial surgery and chemotherapy; future FDA discussions to explore accelerated developmen ...
TUSTIN, CA: TUSTIN, CA -- (Marketwired) -- 12/09/14 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (NASDAQ: PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on ...
FORT COLLINS, CO: Interim Phase 1/2 Data Presented at American Society of Hematology ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 12/09/14 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation") is pleased to announce that it has closed it ...
BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 12/09/14 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the Company will host a live webcast in conjunction with its Research and Development ...
OKLAHOMA CITY, OK: OKLAHOMA CITY, OK -- (Marketwired) -- 12/09/14 -- Cytovance® Biologics, Inc., a leading biopharmaceutical contract manufacturing company, announced the promotion of Donald Wuchterl to Chief Operatin ...
BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 12/08/14 -- Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, d ...
BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 12/08/14 -- Dynavax Technologies Corp. (NASDAQ: DVAX) today announced that the Company and AstraZeneca AB ("AstraZeneca") signed an amendment to the existin ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 12/06/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced new preliminary data from the Phase 2 component of an ongoing Company-sponsored Phase ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 12/05/14 -- (NASDAQ: ATOS) today announced that it has received "establishment inspection reports," or EIRs, from the U.S. Food and Drug Administration, Offi ...
TAMPA, FL: TAMPA, FL -- (Marketwired) -- 12/04/14 -- Ally Pharma US, Inc. (OTCBB: ALPHD) today announced that it completed a merger on September 30, 2014 with TPT Global Tech, Inc., a San Diego, California-base ...
CORONA, CA: CORONA, CA -- (Marketwired) -- 12/04/14 -- SOHM, Inc. (OTC PINK: SHMN), a manufacturer of generic Pharmaceutical, Nutraceutical and Cosmeceutical drug products, today announces the appointment and jo ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/04/14 -- SignalChem Lifesciences Corp. ("SLC"), has dosed its first patient in a Phase 1a clinical trial studying the safety and tolerabi ...
EDMONTON, ALBERTA: - Grant supports collaboration with University of Alberta to advance Ceapro's proprietary high-purity dry form Beta Glucan into an active ingredient in functional food - ...
